↗3 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$1.3MSold on the market
1Companies
Oct 1, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 202618:00 | Sep 29, 2026 | RVMDRevolution Medicines, Inc. | Chief Development Officer | S · Sell10b5-1 | $202.14 | −6,309 | 52,559 | -11% | −$1.3M | ||
| Oct 1, 202618:00 | Sep 29, 2026 | RVMDRevolution Medicines, Inc. | Chief Development Officer | M · Exercise10b5-1 | $58.84 | +6,000 | 58,868 | +11% | $353K | ||
| Sep 18, 202618:06 | Sep 16, 2026 | RVMDRevolution Medicines, Inc. | Chief Development Officer | S · Sell10b5-1 | $199.24 | −341 | 52,868 | -1% | −$68K |